ISSN: 2332-0877

Revista de terapia y enfermedades infecciosas

Acceso abierto

Nuestro grupo organiza más de 3000 Series de conferencias Eventos cada año en EE. UU., Europa y América. Asia con el apoyo de 1.000 sociedades científicas más y publica más de 700 Acceso abierto Revistas que contienen más de 50.000 personalidades eminentes, científicos de renombre como miembros del consejo editorial.

Revistas de acceso abierto que ganan más lectores y citas
700 revistas y 15 000 000 de lectores Cada revista obtiene más de 25 000 lectores

Abstracto

Omics Technologies: A Hope for Translational Research in Bovine Tuberculosis

Gloria Guillermina Guerrero

Bovine tuberculosis diagnosis is one of the main challenges faced by animal and public health systems. The incidence of M. bovis infections remains undefined in developed countries. So it is necessary to carry out an extensive study and surveillance to determine the status of bovine tuberculosis as an urgent need for control eradication program. Furthermore, developed countries, microbiological (bacteriological) and immunological (histochemistry) techniques are still used, making more difficult to homogenize epidemiological knowledge of bTB. Recent reports describing the potential of microarray technology not only to explore subunit vaccine agents (biomarkers), but to pinpoint immunomodulation, and signatures in the journey of pathogen interaction with the host in bovine tuberculosis. Omics and next generation high-throughput technologies have risen as promising tools that will enable translational research (development of prognostic and diagnostic methods with high accuracy and sensibility) and in depth molecular analysis even at single cell level to underpin dynamics in the transcripts regulation of the host response in bTB.

Descargo de responsabilidad: este resumen se tradujo utilizando herramientas de inteligencia artificial y aún no ha sido revisado ni verificado.